ProJenX Funding & Investors
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.
projenx.comTotal Amount Raised: $21,100,000
ProJenX Funding Rounds
Grant
$1,000,000
Grant Investors
The ALS AssociationSeries A
$15,000,000
Series A Investors
Medical Excellence CapitalSeed
$5,100,000
Seed Investors
Medical Excellence Capital
Funding info provided by Diffbot.